The data and safety monitoring going on Monday afternoon contacted me on April 27 first on Friday the week before and then again on April 27th, and notified the study team namely the multiple investigators who are doing the study throughout the world that the data shows That ram Desa via has a clear cut significant positive effect in diminishing the time to recovery.
This is really quite important for a number of reasons.
And I'll give you the data.
It's highly significant if you look at the time to recovery being shorter than the rest of your arm.
It was 11 days.
Compared to 15 days, that's a p value for the scientists to a listening of 0.001.
So that's something that although a 31% improvement, doesn't seem like a knockout hundred percent, it is a very important proof of concept.
Because what it is proven is that a drug can block this virus.
And I'll give you an example in a moment of why we think looking forward.
This is very optimistic.
The mortality rate trended towards being better in the sense of less deaths in the room, decibel group.
8% versus 11% in the placebo group, it has not yet reached statistical significance, but the data needs to be further analysed.
The reason why we're making the announcement now is something that I believe people don't fully appreciate.
Whenever you have clear cut evidence that drug works.
Placeb You have an ethical obligation t immediately let the people who are in the placebo group know, so that they could have access.
And all of the other trials that are taking place now have a new standard of care.
So we would have normally waited several days until the data gets further, dot the i and cross the t.
But the data are not gonna change, some of the numbers may change a little but the conclusion will not change